Aplaviroc: Suspended Phase III enrollment

GSK suspended enrollment of the placebo-controlled Phase III ASPIRE II trial in 406 treatment-experienced patients infected with R5-tropic strain of HIV. The suspension resulted after 2 treatment-naïv...